Bridgeway Capital Management’s Surmodics SRDX Stock Holding History

Bridgeway Capital Management’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-9,600	Closed	-$298K	–	1443
2017 Q3	$298K	Hold	9,600	–	–	﹤0.01%	1208
2017 Q2	$270K	Sell	9,600 -14,750	-61%	-$356K	﹤0.01%	1227
2017 Q1	$586K	Hold	24,350	–	–	0.01%	1016
2016 Q4	$618K	Buy	24,350 +5,400	+28%	+$142K	0.01%	998
2016 Q3	$570K	Buy	+18,950	New	+$521K	0.01%	1029
2015 Q2	–	Sell	-18,500	Closed	-$482K	–	1528
2015 Q1	$482K	Hold	18,500	–	–	0.01%	1109
2014 Q4	$409K	Hold	18,500	–	–	0.01%	1136
2014 Q3	$336K	Hold	18,500	–	–	0.01%	1238
2014 Q2	$396K	Hold	18,500	–	–	0.01%	1188
2014 Q1	$418K	Buy	+18,500	New	+$452K	0.01%	1152

Other funds holding SRDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Teton Advisors Rye, New York $173M AUM 77.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bridgeway Capital Management's SRDX Position: Q4 2017 in Review

Bridgeway Capital Management sold out of Surmodics (SRDX) in Q4 2017, closing a stake of 9,600 shares — an estimated $298K sold.

Bridgeway Capital Management first reported a position in SRDX in Q1 2014 and held it in 10 quarters. The position peaked at $618K in Q4 2016. 115 funds tracked by Wall St. Rank hold SRDX as of Q4 2017.

Bridgeway Capital Management reported no remaining Surmodics position as of Q4 2017 after selling out during the quarter.
Bridgeway Capital Management sold 9,600 Surmodics shares in Q4 2017, an estimated $298K.
Bridgeway Capital Management first reported a position in Surmodics in Q1 2014 and held it in 10 quarters.
Bridgeway Capital Management's Surmodics position peaked at $618K in Q4 2016.
115 funds tracked by Wall St. Rank held Surmodics as of Q4 2017.

Based on Bridgeway Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.